Welcome to the MedEdicus Learning Portal

 
 
 
 
 
 
 
 
 

Case-Based Continuing Education for Health Care Professionals

Join your clinician colleagues who have earned free CME/CE credits here, gaining relevant, useful knowledge and skills that have enhanced the care they provide. 

Create an account, login, and learn something new today! 

NOTE: If you were a user on our previous platform you will need to register (top right corner). It's quick!

Continuing Education Course Library

  • Podcast
  • Ophthalmology
  • Optometry
This podcast, with Kenneth A. Beckman, MD, FACS, and Jaclyn Garlich, OD, delves into the presentation and treatments of evaporative dry eye primarily caused by meibomian gland dysfunction.
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 COPE
    • 0.50 Participation
  • Symposium / Meeting
  • Optometry
Join Walter O. Whitley, OD, MBA, FAAO, at a dinner meeting on dry eye disease on Wednesday, February 21, 2024, in Bethesda, Maryland
    • 2.00 COPE
  • Symposium / Meeting
  • Optometry
Join Ian Benjamin Gaddie, OD, FAAO, at a dinner meeting on dry eye disease on Thursday, February 22, 2024, in Chicago, Illinois
    • 2.00 COPE
  • Symposium / Meeting
  • Optometry
Join Walter O. Whitley, OD, MBA, FAAO, at a dinner meeting on dry eye disease on Thursday, February 22, 2024, in Dunwoody (Atlanta), Georgia
    • 2.00 COPE
  • Symposium / Meeting
  • Optometry
Join Ian Benjamin Gaddie, OD, FAAO, at a dinner meeting on dry eye disease on Wednesday, March 20, 2024, in Columbus, Ohio
    • 2.00 COPE
  • Symposium / Meeting
  • Optometry
Join Ian Benjamin Gaddie, OD, FAAO, at a dinner meeting on dry eye disease on Thursday, March 21, 2024, in Rosemont, Illinois
    • 2.00 COPE
  • Symposium / Meeting
  • Optometry
Join Melissa Barnett, OD, FAAO, FSLS, FBCLA, at a dinner meeting on dry eye disease on Thursday, March 7, 2024, in Santa Ana, California
    • 2.00 COPE
  • Symposium / Meeting
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
Earn up to 1.0 Credit at this CME symposium - Monday, March 4, 2024, in Honolulu, Hawaii
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
  • Monograph
  • Ophthalmology
  • Ophthalmology/Neuro-Ophthalmic
This educational activity is intended to help clinicians evaluate real-world data pertaining to hearing dysfunction associated with thyroid eye disease treatment with the insulin-like growth factor 1 receptor antagonist teprotumumab.
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Participation

Pages

My Completed Courses

Please login or create an account to view your activities.

My Pending Courses

Please login or create an account to view your activities.